Drug Safety Surveillance Services include:

	Strategic planning
	24 hours/seven days per week coverage
	Clinical protocol program development
	Adverse event coding
	Post-marketing surveillance
	SAE Processing
	Regulatory report generation
	Regulatory submissions support
	Clinical Protocol Safety Section Development
	Serious adverse event (SAE) processing
	Safety evaluation and annual safety update services
	Investigator/Site Training
	Reconciliation Services - Safety/Clinical Databases
	Regulatory Reporting (MedWatch, CIOMs)
	Reports to Investigators/IRBs
	Periodic Safety Update Reports (PSURs)
	Annual Report